0000899243-23-010574.txt : 20230404
0000899243-23-010574.hdr.sgml : 20230404
20230404203917
ACCESSION NUMBER: 0000899243-23-010574
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230331
FILED AS OF DATE: 20230404
DATE AS OF CHANGE: 20230404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Camerlinck Robert
CENTRAL INDEX KEY: 0001942114
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39289
FILM NUMBER: 23800843
MAIL ADDRESS:
STREET 1: 9725 NW 117TH AVENUE, SUITE 200
CITY: MIAMI
STATE: FL
ZIP: 33178
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cano Health, Inc.
CENTRAL INDEX KEY: 0001800682
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9725 NW 117TH AVENUE, SUITE 200
CITY: MIAMI
STATE: FL
ZIP: 33178
BUSINESS PHONE: 2034227700
MAIL ADDRESS:
STREET 1: 9725 NW 117TH AVENUE, SUITE 200
CITY: MIAMI
STATE: FL
ZIP: 33178
FORMER COMPANY:
FORMER CONFORMED NAME: Jaws Acquisition Corp.
DATE OF NAME CHANGE: 20200121
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-03-31
0
0001800682
Cano Health, Inc.
CANO
0001942114
Camerlinck Robert
CANO HEALTH, INC.
9725 NW 117TH AVENUE
MIAMI
FL
33178
0
1
0
0
Chief Operating Officer
0
Class A Common Stock
2023-03-31
4
A
0
70486
A
23913609
D
Stock Option (Right to Buy)
0.91
2023-03-31
4
A
0
147548
0.00
A
2033-03-31
Class A Common Stock
147548
147548
D
These shares represent restricted stock units ("RSUs") granted under the Cano Health, Inc. 2021 Stock Option and Incentive Plan. Each unit represents a right to receive one share of the Issuer's Class A Common Stock. The RSUs vest as to 50% of the RSUs on December 31st, 2023 and the remaining 50% of the RSUs vest on December 31st, 2024. The RSUs were granted on March 31, 2023.
The stock option is granted under the Cano Health, Inc. 2021 Stock Option and Incentive Plan and is scheduled to vest over four years, with 25% of the shares underlying the award vesting on March 31, 2024, and 25% of the shares underlying the award vesting at the end of each successive one-year period thereafter. The stock option was granted on March 31, 2023.
/s/ David J. Armstrong, Attorney-in-Fact
2023-04-04